1. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010; 53:397–417.
2. Hwangbo Y, Jung JH, Shim J, Kim BH, Jung SH, Lee CK, et al. Etiologic and laboratory analyses of ascites in patients who underwent diagnostic paracentesis. Korean J Hepatol. 2007; 13:185–95.
3. Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987; 7:122–8.
4. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003; 38:258–66.
5. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992; 117:215–20.
6. al Karawi MA, Mohamed AE, Yasawy MI, Graham DY, Shariq S, Ahmed AM, et al. Protean manifestation of gastrointestinal tuberculosis: report on 130 patients. J Clin Gastroenterol. 1995; 20:225–32.
7. Runyon BA; AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009; 49:2087–107.
8. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology. 2000; 32(4 Pt 1):689–92.
9. DeSitter L, Rector WG Jr. The significance of bloody ascites in patients with cirrhosis. Am J Gastroenterol. 1984; 79:136–8.
10. Runyon BA, Akriviadis EA, Keyser AJ. The opacity of portal hypertension-related ascites correlates with the fluid’s triglyceride concentration. Am J Clin Pathol. 1991; 96:142–3.
11. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006; 55(Suppl 6):vi1–12.
12. Evans TW. Review article: albumin as a drug. Biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002; 16(Suppl 5):6–11.
13. Cho J, Jensen TP, Reierson K, Mathews BK, Bhagra A, Franco-Sadud R, et al. Recommendations on the use of ultrasound guidance for adult abdominal paracentesis: a position statement of the Society of Hospital Medicine. J Hosp Med. 2019; 14:E7–15.
14. Omary RA, Bettmann MA, Cardella JF, Bakal CW, Schwartzberg MS, Sacks D, et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol. 2003; 14(9 Pt 2):S293–5.
15. Tirkes T, Sandrasegaran K, Patel AA, Hollar MA, Tejada JG, Tann M, et al. Peritoneal and retroperitoneal anatomy and its relevance for cross-sectional imaging. Radiographics. 2012; 32:437–51.
16. Churg A, Cagle PT, Roggli VL. Tumors of the serosal membranes. Washington, DC: American Registry of Pathology;2006.
17. Hanbidge AE, Lynch D, Wilson SR. US of the peritoneum. Radiographics. 2003; 23:663–84.
18. Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986; 146:2259–61.
19. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991; 31:164–71.
20. Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther. 2005; 21:525–9.
21. Mercaldi CJ, Lanes SF. Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. Chest. 2013; 143:532–8.
22. Patel PA, Ernst FR, Gunnarsson CL. Evaluation of hospital complications and costs associated with using ultrasound guidance during abdominal paracentesis procedures. J Med Econ. 2012; 15:1–7.